Orion (NYSE:OEC) Price Target Lowered to $22.00 at UBS Group

Orion (NYSE:OECFree Report) had its target price decreased by UBS Group from $23.00 to $22.00 in a report released on Thursday morning,Benzinga reports. UBS Group currently has a buy rating on the specialty chemicals company’s stock.

Separately, JPMorgan Chase & Co. raised shares of Orion from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $20.00 to $21.00 in a research note on Monday, November 11th.

View Our Latest Research Report on OEC

Orion Stock Up 3.3 %

OEC opened at $15.15 on Thursday. The business’s fifty day simple moving average is $15.00 and its 200 day simple moving average is $16.44. Orion has a 52 week low of $13.32 and a 52 week high of $26.05. The company has a quick ratio of 0.71, a current ratio of 1.24 and a debt-to-equity ratio of 1.42. The stock has a market cap of $874.52 million, a PE ratio of 20.20 and a beta of 1.50.

Orion (NYSE:OECGet Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The specialty chemicals company reported $0.35 EPS for the quarter, beating the consensus estimate of $0.25 by $0.10. The firm had revenue of $434.20 million for the quarter, compared to analyst estimates of $437.03 million. Orion had a return on equity of 20.94% and a net margin of 2.35%. As a group, research analysts expect that Orion will post 1.73 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Orion

Institutional investors and hedge funds have recently bought and sold shares of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Orion by 30.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 118,937 shares of the specialty chemicals company’s stock valued at $1,878,000 after purchasing an additional 27,804 shares during the period. Two Sigma Investments LP purchased a new stake in Orion during the 4th quarter valued at $382,000. ProShare Advisors LLC grew its holdings in Orion by 49.0% in the 4th quarter. ProShare Advisors LLC now owns 16,214 shares of the specialty chemicals company’s stock worth $256,000 after acquiring an additional 5,335 shares during the last quarter. Nuveen Asset Management LLC increased its position in shares of Orion by 20.3% in the fourth quarter. Nuveen Asset Management LLC now owns 694,579 shares of the specialty chemicals company’s stock valued at $10,967,000 after acquiring an additional 117,022 shares during the period. Finally, Numerai GP LLC raised its stake in shares of Orion by 97.4% during the fourth quarter. Numerai GP LLC now owns 52,484 shares of the specialty chemicals company’s stock valued at $829,000 after acquiring an additional 25,895 shares during the last quarter. 94.33% of the stock is currently owned by institutional investors.

About Orion

(Get Free Report)

Orion SA, together with its subsidiaries, engages in the manufacture and sale of carbon black products. It operates in two segments, Specialty Carbon Black and Rubber Carbon Black. The company offers post-treated specialty carbon black grades for coatings and printing applications; high purity carbon black grades for the fiber industry; and conductive carbon black grades for batteries, polymers, and coatings.

See Also

Receive News & Ratings for Orion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion and related companies with MarketBeat.com's FREE daily email newsletter.